Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET

DRUG2 trials

Sponsors

Clinical Hub for Interventional Research (CHOIR), PETHEMA Foundation

Conditions

Acute Myeloid LeukemiaAcute Myeloid Leukemia With Gene MutationsChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes

Phase 1

Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS

RecruitingNCT05636514

Clinical Hub for Interventional Research (CHOIR)Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes

Start: 2022-12-14End: 2027-12-30Target: 12Updated: 2026-03-18

Phase 2

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

RecruitingNCT07507760

PETHEMA FoundationAcute Myeloid Leukemia With Gene Mutations

Start: 2026-06-12End: 2029-04-01Target: 50Updated: 2026-09-02